Newsroom
For the latest team, company and product news from Huma
Newsroom
For the latest team, company and product news from Huma
Press Releases
Media Coverage
2025
Huma Deploys Hi Scribe to Automate Clinical Documentation and Billing Using AI
Huma Announces Partnership with Eckuity Capital to Accelerate M&A and Acquires Aluna
Huma Therapeutics Receives Health Canada Class II Medical Device License for Huma Cloud Platform
Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia
Huma and Wheel partner to deliver a Direct-to-Consumer Platform as a Service
Samsung, Huma and Tulane University’s HEARTBEAT 10,000 Study Enrolls First Patient
2024
Huma acquires eConsult and launches Huma Workspace for Health Systems
Huma Launches App to Support Patients with Glioma
Huma Secures Clearance for Class C Medical Device Certification in India
Eczacibasi Evital and Huma collaborate in digital health
Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital-first care and research to everyone
Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
2023
Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform
Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care
Huma collaborates with Google Cloud to improve healthcare through generative AI
Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform
Huma named for its successful and innovative approach to clinical trials in new UK government review
UCB and Huma partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis
Huma receives world’s first and only multi-condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform
How our Huma app drives engagement in population health research
Largest decentralised study of its kind shows high levels of engagement with Huma’s study app
Huma acquires Alcedis, one of the world's leading digital clinical trials companies
2022
Keeping patients safe at home with virtual wards
Increasing clinical trial success rates with adaptive technology
Fixing the foundations: building a solid evidence base for digital health
How to design virtual wards: 5 tips to set you up for success
How Huma technology can reduce burnout on virtual wards
Press Releases
Media Coverage
2025
Huma Deploys Hi Scribe to Automate Clinical Documentation and Billing Using AI
Huma Announces Partnership with Eckuity Capital to Accelerate M&A and Acquires Aluna
Huma Therapeutics Receives Health Canada Class II Medical Device License for Huma Cloud Platform
Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia
Huma and Wheel partner to deliver a Direct-to-Consumer Platform as a Service
Samsung, Huma and Tulane University’s HEARTBEAT 10,000 Study Enrolls First Patient
2024
Huma acquires eConsult and launches Huma Workspace for Health Systems
Huma Launches App to Support Patients with Glioma
Huma Secures Clearance for Class C Medical Device Certification in India
Eczacibasi Evital and Huma collaborate in digital health
Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital-first care and research to everyone
Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
2023
Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform
Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care
Huma collaborates with Google Cloud to improve healthcare through generative AI
Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform
Huma named for its successful and innovative approach to clinical trials in new UK government review
UCB and Huma partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis
Huma receives world’s first and only multi-condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform
How our Huma app drives engagement in population health research
Largest decentralised study of its kind shows high levels of engagement with Huma’s study app
Huma acquires Alcedis, one of the world's leading digital clinical trials companies
2022
Keeping patients safe at home with virtual wards
Increasing clinical trial success rates with adaptive technology
Fixing the foundations: building a solid evidence base for digital health
How to design virtual wards: 5 tips to set you up for success
How Huma technology can reduce burnout on virtual wards
About Huma